Aravdeep Jhand
Interventional Cardiology · Rochester, MNNPI 1487100731
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (47.9%), food and beverage and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Edwards Lifesciences at 29.7% of the total. Reporting peaked in 2022 at $3,182 and has fallen 92.3% since, to $245 in 2025.
Across 77 payments — averaging $94.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$2K
- Medtronic$2K
- Abbott$1K
- W. L. Gore & Associates, Inc.$989
- Boston Scientific$252
- Philips North America LLC$170
- plus $832 from 8 others
What the payments were for
- Travel & lodging$3,48648%
- Food & beverage$3,04642%
- Education$74710%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 23 | $2,165 |
| Medtronic | 16 | $1,731 |
| Abbott | 14 | $1,141 |
| W. L. Gore & Associates, Inc. | 6 | $989 |
| Boston Scientific | 5 | $252 |
| Philips North America LLC | 2 | $170 |
| Astellas Pharma US Inc | 2 | $170 |
| Abiomed | 2 | $157 |
| Cardiovascular Systems Inc. | 1 | $148 |
| Heartflow, Inc. | 1 | $124 |
| GE HealthCare | 1 | $100 |
| Chiesi USA, Inc. | 1 | $79 |
| Asahi Intecc USA, Inc. | 2 | $37 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RESOLUTE ONYX$1,343
- GORE CARDIOFORM Septal Occluder$827
- Edwards SAPIEN 3 Transcatheter Heart Valve$768
- HeartMate 3 Left Ventricular Dev$338
- SAPIEN 3 Ultra RESILIA$237
- EnSite Precision Cardiac Mapping System$166
- Diamondback Coronary$148
- CardioMEMS HF System$147
- (9520) IGT Devices Undivided$147
- FFRct$124
- OPTIS$112
- Ensite Cardiac Mapping System$112
- PERCLOSE PROGLIDE$107
How this compares
$7,279 in reported general payments places this provider in the 55th percentile of 84 interventional cardiology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 12 | $88 |
| ClopidogrelClopidogrel Bisulfate | 21 | $24 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Rochester
- Kelley ChenRochester$14K
- Colleen LaneRochester$14K
- Smitha Narayana GowdaRochester$9K
- Trevor SimardRochester$9K
- Michael SabbahRochester$8K
- Joshua RezkallaRochester$5K
- Mohammed OsmanRochester$4K
- Mohammad SarrafRochester$3K
- Jason SimsRochester$2K
- Conor LaneRochester$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.